Skip to Main Content

Paper Details

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.
Curr Oncol
2
2021

Datasets

Release 1.2